Corcept Therapeutics
CORT
CORT
208 hedge funds and large institutions have $1.03B invested in Corcept Therapeutics in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 78 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 41
39% less call options, than puts
Call options by funds: $5M | Put options by funds: $8.24M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
208
Holding in Top 10
1
Calls
$5M
Puts
$8.24M
Top Buyers
| 1 | +$4.82M | |
| 2 | +$4.74M | |
| 3 | +$3.75M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.41M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.39M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$6.08M | |
| 3 | -$5.39M | |
| 4 |
Morgan Stanley
New York
|
-$5.32M |
| 5 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$5.1M |